BeOne Medicines, BGB-B2033, BGB-58067, BG-C477, BGB-43395, ESMO 2026, Hepatocellular Carcinoma, HCC, Non-Small Cell Lung Cancer, NSCLC, Breast Cancer, GPC3, 4-1BB,

SAN CARLOS, Calif. — October 24, 2026 BeOne Medicines Ltd. announced new clinical data from multiple investigational medicines at...